Amwell to Report Third Quarter 2023 Operating Results and Host Conference Call on Wednesday, Nov. 1, 2023

Rhea-AI Summary

Amwell to report Q3 2023 operating results and host conference call

Positive

• Amwell will report its third-quarter 2023 operating results on November 1, 2023
• Investors can access a live audio webcast of the conference call on the company's website
• A replay of the call will be available for on-demand listening

Negative

• None.

BOSTON--(BUSINESS WIRE)-- Amwell^® (NYSE: AMWL), a leader in hybrid health care enablement, today announced it will report its third-quarter 2023 operating results on Wednesday, November 1, 2023. Following distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. Eastern time to review the company's operating results and provide a general business update.

A live audio webcast can be accessed by visiting the Investors section of the company's website at investors.amwell.com. Alternatively, please call (888) 510-2008 (U.S.) or (646) 960-0306 (International) to listen to the live conference call. The conference ID number for the live call will be 7830032. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

About Amwell

Amwell provides a leading hybrid care enablement platform in the United States and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. The company offers a single, comprehensive platform designed to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With nearly two decades of experience, Amwell powers the hybrid care of more than 55 health plans, which collectively represent more than 90 million covered lives, and many of the nation’s largest health systems, representing over 2,000 hospitals, have access to Amwell solutions. For more information, please visit https://business.amwell.com/.

©2023 American Well Corporation. All rights reserved. Amwell^®, SilverCloud^®, Converge^™, Carepoint^™ and the Amwell Logo are registered trademarks or trademarks of American Well Corporation.

Forward-Looking Statements

This press release contains forward-looking statements about us and our industry that involve substantial risks and uncertainties and are based on our beliefs and assumptions and on information currently available to us. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations, financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” or “would,” or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements represent our beliefs and assumptions only as of the date of this release. These statements, and related risks, uncertainties, factors and assumptions, include, but are not limited to: weak growth and increased volatility in the telehealth market; inability to adapt to rapid technological changes; increased competition from existing and potential new participants in the healthcare industry; changes in healthcare laws, regulations or trends and our ability to operate in the heavily regulated healthcare industry; our ability to comply with federal and state privacy regulations; the significant liability that could result from a cybersecurity breach; and other factors described under ‘Risk Factors’ in our most recent form 10-K filed with the SEC. These risks are not exhaustive. Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future. Further information on factors that could cause actual results to differ materially from the results anticipated by our forward-looking statements is included in the reports we have filed or will file with the Securities and Exchange Commission. These filings, when available, are available on the investor relations section of our website at investors.amwell.com and on the SEC’s website at www.sec.gov.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231018878356/en/

Investors:

Sue Dooley

Sue.dooley@amwell.com

415-602-9167

Press:

Angela Vogen

press@amwell.com

Source: Amwell

FAQ

When will Amwell report its Q3 2023 operating results?

Amwell will report its third-quarter 2023 operating results on November 1, 2023.

How can investors access the conference call?

Investors can access a live audio webcast of the conference call on the company's website.

Will there be a replay of the conference call?

Yes, a replay of the call will be available for on-demand listening.